Improved treatment satisfaction in patients with type 1 diabetes treated with insulin glargine 100Â U/mL versus neutral protamine Hagedorn insulin: An exploration of key predictors from two randomized controlled trials

Gla-100 resulted in a significant improvement in treatment satisfaction versus NPH insulin, independent of baseline disease characteristics and clinical outcomes.